Latest news, reports, and more from the RedChip Nation.
 
Discovering Tomorrow's Blue Chips Today
May 5, 2021     Contact    
Featured This Week
 
RedChip Welcomes Palisade Bio (Nasdaq: PALI)
 

 


Palisade Bio began trading on the Nasdaq on April 28 under the ticker PALI. Formed by the reverse merger of Seneca BioSciences (Nasdaq: SNCA) and privately held Leading BioSciences, PALI is developing novel therapeutics designed to improve human health through therapeutic protection of the gastrointestinal (GI) mucosal barrier. PALI’s lead asset, LB1148, is in an ongoing Phase 2 trial in GI surgery and is entering a Phase 3 study in neonatal cardiac surgeries in the second quarter this year. The Company anticipates that this clinical trial will enroll 100 patients and that it will have data from the first 10 patients in late 2021 with final data from the full study in 2022. Learn more at www.PALIinfo.com.

 
 >
Latest News
 
Nano Dimension (NASDAQ: NNDM) Acquires Micro Mechanics 3D-Printing Leader, NanoFabrica Ltd.
 >
Can-Fite (NYSE American: CANF) Phase III Psoriasis Study Achieves 75% Enrollment; Top Line Results Expected Q4 2021
 >
Annovis Bio (NYSE American: ANVS) to Study Potential of ANVS401 to Normalize Brain Development in Down Syndrome
 
 
Hut 8 Mining (OTCQX: HUTMF) Names Ronnie Yu Head of Sustainability
 
 
Hut 8 Partners (OTCQX: HUTMF) with Galaxy Digital on Tailored Lending Solution
 
 
Lantern Pharma (NASDAQ: LTRN) Announces Publication Detailing Preclinical Results of Drug Candidate, LP-184, in a Spectrum of Drug-Resistant Lung Cancers in the Journal Oncotarget
 
 
Lantern Pharma (NASDAQ: LTRN) Proprietary A.I. Platform for Precision Oncology Drug Development, RADR®, Surpasses 4.6 Billion Datapoints, Accelerating the Company's Progress in the Development of Biopharma Collaborations and Partnerships and Advancing the Company's Strategy to Develop the World's Largest A.I. Platform for Oncology-Focused Drug Development & Rescue
 
 
Genetic Technologies (NASDAQ: GENE) COVID-19 Risk Test Approved for Commercial Release
 
 
BioVie (NASDAQ: BIVI) Acquires Biopharma Assets from Privately Held NeurMedix
 
 
Red Cat Holdings (NASDAQ: RCAT) Announces Pricing of $16 Million Public Offering and Nasdaq Listing
 
 
Nemaura Medical (NASDAQ: NMRD) Issues Letter to Shareholders Following April 28 Shareholder Update Call
 
 
1847 Holdings (OTCQB: EFSH) Increases Shareholders' Equity to $6.7M through Sale of Neese Subsidiary
 
 
SPI Energy’s (NASDAQ: SPI) Solar American Appoints 13-Year Solar Industry Veteran Chad Pricolo as SVP of Consumer Operations
 
 
SPI Energy’s (NASDAQ: SPI) Phoenix Motorcars Appoints Auto Tech Veteran Ron Iacobelli as its New CTO
 
 
SPI Energy (NASDAQ: SPI) Reports Revenue Up 42% to Record $138.6M in Fiscal Year 2020
 
 
American Resources (NASDAQ: AREC) Announces Progress of Fly Ash Sampling Program
 
 
RYU Apparel (OTCQB: RYPPF) Announces 50 Free Tickets with Purchase to Annual Canucks Country Rocks Livestream Concert Benefiting Mental Health Not-For-Profit Organizations
 
 
Elixinol (OTCQB: ELLXF) Introduces the First CBD Capsules Powered by Ginfort
 
 
DSG Global (OTCQB: DSGT) Establishes Its First North American Manufacturing and R&D Facility
 
 
 
Upcoming Zoom Webinar
 

Join Zoom Meeting: zoom.us/j/98621906032
One tap mobile
US: +1 646 558 8656 or +1 301 715 8592 or +1 312 626 6799 or
+1 669 900 9128 or +1 253 215 8782 or +1 346 248 7799
Or Telephone:
Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 986 2190 6032
Passcode: 262135
International numbers available:
zoom.us/u/ab01fs09MW


 
 
 
 

Join Zoom Meeting: zoom.us/j/95504618970
Or iPhone one-tap : US: +13017158592,,95504618970# or +13126266799,,95504618970# Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 955 0461 8970
International numbers available:
zoom.us/u/abTfhsoo93


 
 
 
 

Join Zoom Meeting: zoom.us/j/92124350712
Or iPhone one-tap : US: +13017158592,,92124350712#,,,,*266459# or +13126266799,,92124350712#,,,,*266459# Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 921 2435 0712
Passcode: 266459
International numbers available:
zoom.us/u/aBL51u7hl


 
 
 
 
 
 
 
Quote of the Week
 
"You’ve got to make a decision to devote a decade of your life to something. It takes 10 years of your life to accomplish anything."
- Manny Villafana, CEO Kips Bay Medical
 
 
 
Lesson of the Week
 
This week we talk about value investing, a concept that originated more than 70 years ago by Benjamin Graham.
Read More
 
 
 

 

Latest Videos
 
 
This Week on RedChip TV: 3 Small-Cap Stocks Set to Win in 2021
 
This week’s episode of the RedChip Money Report features interviews with senior executives from Recruiter.com (OTCQB: RCRT), Aptorum (NASDAQ: APM), and Medalist Diversified REIT (NASDAQ: MDRR). Visit RedChip.com to learn more.
 
Watch Now
 
 
 
 
Amesite: AI-Driven EdTech Transforming Learning
 
Amesite (Nasdaq: AMST) is an ed-tech, SaaS company with the most advanced artificial intelligence driven online learning platform in the industry, providing both content creation and a best-in-class infrastructure for the multi-billion-dollar online learning markets in business and education. The Company leverages existing institutional infrastructures, adding mass customization and cutting-edge technology to provide cost-effective, scalable, and engaging experiences for learners anywhere.
 
Watch Now
 
 
 
 
CBD of Denver Interviewed on Benzinga’s Cannabis Insider
 
CBD of Denver (CBDD) is a full-line CBD and hemp oil company, producing and distributing cannabis and CBD products in Switzerland, Europe, and the US. CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for its shareholders and is driven by a passion to improve lives and strengthen communities by unleashing the full potential of cannabis.
 
Watch Now
 
 
 
 
Tiziana Life Sciences: Robust Pipeline with Multiple Near-Term Catalysts
 
Tiziana Life Sciences (NASDAQ: TLSA) has developed proprietary oral, nasal, and inhaled formulation technologies that could transform immunotherapies with Monoclonal Antibodies currently administered intravenously for multiple indications.
 
Watch Now
 
 
 
 
Milestone Scientific: Leading Injection Technology Innovator
 
Milestone Scientific (NYSE American: MLSS) is a leading medical research and development company that designs and patents innovative injection technology. The Company’s clinically validated, patented, computer-controlled systems make injections precise, efficient, and virtually painless, addressing unmet needs and providing a potential new standard of care in anesthesia.
 
Watch Now
 
 
 
 
Medalist Diversified REIT: Targeting Attractive Opportunities in Secondary Markets in Southeast U.S.
 
Medalist Diversified REIT (NASDAQ: MDRR) was founded in 2003 as a private equity company specializing in acquiring, owning, and managing commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent, and replicable process for sourcing and conducting due diligence of acquisitions.
 
Watch Now
 
 
 
 
Recruiter.com: Transforming the World of Recruiting
 
Recruiter.com (OTCQB: RCRT) is a hiring platform for the world’s largest network of recruiters. Recruiter.com empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology. The Recruiter.com network of over 28,000 small and independent recruiters utilize an innovative web platform, complete with AI-driven job matching, screening and video interviewing to recruit talent faster.
 
Watch Now
 
 
 
 
DeFi Technologies: Transforming Global Finance
 
Led by co-founders Wouter Witvoet and Olivier Roussy Newton, who collectively raised $1.4B in their prior two deals, DeFi Technologies (OTC: DEFTF) is well positioned to become a key player in the rapidly growing decentralized finance industry. The market size for the industry is measured in the trillions and spans multiple sectors, including insurance, derivatives, credit and lending, asset management, and exchanges.
 
Watch Now
 
 
 
 
Virios Therapeutics: Potential Treatment Paradigm Shift for Fibromyalgia
 
Virios Therapeutics (Nasdaq: VIRI) is a clinical-stage biotechnology company focused on advancing novel, dual mechanism antiviral therapies to treat conditions associated with virally triggered or maintained immune responses, such as Fibromyalgia (“FM”).
 
Watch Now
 
 
 
 
Aptorum Group: Developing Novel Therapeutics for Unmet Medical Needs
 
Aptorum Group Limited (NASDAQ: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum's current drug pipeline includes indications in orphan diseases, infectious diseases, and metabolic diseases.
 
Watch Now
 
 
 
 
EVmo: Leading Provider of Rental Vehicles for the Gig Economy
 
EVmo (OTC: YAYO) bridges the gap between rideshare drivers in need of a suitable vehicle and rideshare companies that depend on attracting and keeping drivers. EVmo uniquely supports drivers in both the higher and lower economic categories with innovative policies and programs. EVmo is a leading provider of rental vehicles to drivers in the ever-expanding gig economy.
 
Watch Now
 
 
 
 
Killi: Transforming the $247B Market for Personal Data
 
Founded in 2018 and with offices in New York & Toronto, Killi (TSXV: MYID; OTCQB: MYIDD) is a company driven by the evolution of data and privacy. Killi aims to democratize data for consumers by providing them with an ecosystem where they can view, edit, opt-out, and be compensated for the use of their data. Today there is no destination for consumers to participate in the use of their data. Killi aspires to be the destination that consumers visit to reclaim control of their online data.
 
Watch Now
 
 
 
 
Elixinol: Industry Pioneer Set for Rapid Growth
 
Elixinol (OTC: ELLXF) is an original pioneer in the CBD industry — focused on the science, research and development of world-class cannabinoid products that provide real results for real people. A global company with a proven track record of growing and extracting premium-quality hemp, Elixinol's products are sold online at Elixinol.com, at over 2,600 natural, specialty and conventional grocery stores and pharmacies across the U.S., and around the world.
 
Watch Now
 
 
 
 
BTCS: Pioneer in Blockchain Space
 
BTCS Inc. (OTCQB: BTCS) is an early entrant in the digital asset market and one of the first U.S. publicly traded companies focused on digital assets and blockchain technologies. BTCS resumed its transaction verification services business segment in the first quarter of 2021 with a focus on validating transactions and operating nodes on proof-of-stake blockchains.
 
Watch Now
 
 
 
 
Learn Why Robert Blair, The Visionary Architect Behind Lulu Lemon (LULU) Joined RYU Apparel
 
RYU Apparel (OTCQB: RYPPF), or Respect Your Universe, is an award winning urban athletic apparel brand that engages in the development, marketing, and distribution of apparel, bags and accessories. Our products are engineered for the fitness, training and performance of the multi-discipline athlete. Our products are designed, developed and tested at our corporate headquarters in Vancouver, BC, Canada. Production takes place in factories located in North America and Asia.
 
Watch Now
 
 
 
 
Lantern Pharma: Transforming Cancer Drug Development with A.I.
 
Lantern Pharma (Nasdaq: LTNR) is a clinical stage biotechnology company leveraging its RADR® artificial intelligence (“A.I.”) platform to transform the pace, risk and cost of oncology drug development. RADR® A.I. quickly and efficiently develops precise genetic signatures of disease that underpin the identification of patients for whom its portfolio of oncology drug candidates is likely to have the greatest therapeutic effect. Lantern is currently developing three drug candidates in solid tumors.
 
Watch Now
 
 
 
 
Kiromic BioPharma: AI-Driven Immuno-Oncology Therapy Development
 
Kiromic BioPharma (Nasdaq: KRBP) is revolutionizing next-generation allogenic CAR therapies for solid tumors. The Company’s proprietary target discovery engine, Diamond uses AI and a proprietary neural network to identify development targets, dramatically compressing man years and billions of drug development dollars required to develop new live drugs.
 
Watch Now
 
 
 
 
Aridis Pharmaceuticals: Developing Novel Anti-Infective Therapies
 
Aridis Pharmaceuticals (Nasdaq: ARDS) discovers and develops anti-infectives to be used as add-on treatments to standard-of-care antibiotics. The Company is utilizing its proprietary ʎPEXTM and MabIgX® technology platforms to rapidly identify rare, potent antibody-producing B-cells from patients who have successfully overcome an infection, and to rapidly manufacture monoclonal antibody (mAbs) for therapeutic treatment of critical infections.
 
Watch Now
 
 
`
 
 
COMSovereign Corporate Overview with CEO & CTO
 
COMSovereign Holding (Nasdaq: COMS) Chairman & CEO Dan Hodges, along with Chief Technology Officer Dr. Dustin McIntire, share insight into the Company’s portfolio of communications technology companies and how they are expected to drive rapid growth in 2021 and beyond. Through strategic acquisitions and organic research and development efforts, COMSovereign has become a U.S.-based communications provider able to provide 4G LTE Advanced and 5G-NR telecom solutions to network operators and enterprises.
 
Watch Now
 
 
 
 
Hoth Therapeutics: Developing a New Generation of Therapies for Unmet Medical Needs
 
Hoth Therapeutics (Nasdaq: HOTH) is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. Hoth's clinical pipeline is concentrated on drug candidates that improve the quality of life for patients suffering from indications including atopic dermatitis, skin toxicities associated with cancer therapy, chronic wounds, psoriasis, asthma, acne, mast-cell derived cancers & anaphylaxis and pneumonia.
 
Watch Now
 
 
 
 
Can-Fite BioPharma: Advanced Clinical Stage Drug Development
 
Can-Fite BioPharma (NYSE American: CANF) has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases. The company’s platform technology utilizes the Gi protein associated A3 adenosine receptor (A3AR) as a therapeutic target. A3AR is highly expressed in inflammatory and cancer cells where low expression is found in normal cells, suggesting that the receptor could be a unique target for pharmacological intervention.
 
Watch Now
 
 
 
 
Esports Entertainment Group CEO Discusses Plans for Rapid Growth
 
Interview with CEO of Esports Entertainment Group Inc. (NASDAQ: GMBL), a full stack esports and online gambling company fueled by the growth of video-gaming and the ascendance of esports with new generations. Its mission is to help connect the world at large with the future of sports entertainment in unique and enriching ways that bring fans and gamers together. Esports Entertainment Group and its affiliates are well-poised to help fans and players to stay connected and involved with their favorite esports.
 
Watch Now
 
 
 
 
Alset EHome International: Diversified Operations Accelerating Sustainable Healthy Living
 
Alset EHome International (Nasdaq: AEI) is a diversified holding company principally engaged through its subsidiaries in property development, digital transformation technology and biohealth activities with operations in the United States, Singapore, Hong Kong, Australia and South Korea.
 
Watch Now
 
 
 
 
CBD of Denver: Corporate Overview
 
CBD of Denver (OTC: CBDD) is a full-line CBD and hemp oil company, producing and distributing cannabis and CBD products in Switzerland, Europe, and the US. CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for its shareholders and is driven by a passion to improve lives and strengthen communities by unleashing the full potential of cannabis.
 
Watch Now
 
 
 
 
Order Small Stocks, Big Money Today!
 
Dave Gentry is the author of Small Stocks, Big Money: Interviews With Microcap Superstars. Published by Wiley, this first-hand perspective on the fast world of microcap investing is now available for purchase.
 
 
MidSouth Week in Review
 
Both the NASDAQ and S&P made new highs last week.
Read More
 
 
 
 
About RedChip
 
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
 
RedChip Disclosure
 
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures.
 
 
     
 
 
Copyright © 2021 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.